ETHICAL COMPLIANCE REPORT

WINDLAS BIOTECH

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Overall Compliance

compliant

PRIMARY BUSINESS FILTER
Pharmaceuticals
compliant
REVENUE RATIO FILTER
2.1%
View Calculations
DEBT RATIO FILTER
3.6%
View Calculations
LIQUIDITY RATIO FILTER
2.1%
View Calculations

Revenue Ratio

The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.

2.1%

Non Compliant

Questionable

Compliant

CALCULATION

\textbf{Revenue Ratio:} \\[12pt] \dfrac{166240000.00}{7778960000.00} \times 100 = 2.10\%

FORMULA

\textbf{Revenue Ratio:} \\[12pt] \dfrac{\text{Unethical Segments}}{\text{Total Revenue}} \times 100 \; \leq \; 3\%

Segment	Compliance	Value
Other Income	compliant	₹1.39
Sale of Services	compliant	₹0.77
Other Operating Income	compliant	₹4.75
Export Sales	compliant	₹32.63
Interest income	non-compliant	₹1.55
Pharmaceuticals	compliant	₹721.73
Net Gain on Sale of Investments	questionable	₹15.08

Debt Ratio

The interest bearing debt should not exceed 31% of the total assets. This is to ensure that the company is not paying a significant portion of its assets as interest.

3.6%

CALCULATION

\textbf{Debt Ratio:} \\[12pt] \dfrac{271170000.00}{7604500000.00} \times 100 = 3.60\%

FORMULA

\textbf{Debt Ratio:} \\[12pt] \dfrac{\text{Interest Bearing Debt}}{\text{Total Assets}} \times 100 \; \leq \; 30\%

Liquidity Ratio

The total liquid assets should not exceed 90% of the total assets. This is to ensure that trading this stock does not become similar to trading a currency.

2.1%

CALCULATION

\textbf{Liquidity Ratio:} \\[12pt] \dfrac{159270000.00}{7604500000.00} \times 100 = 2.10\%

FORMULA

\textbf{Liquidity Ratio:} \\[12pt] \dfrac{\text{Total Liquid Assets}}{\text{Total Assets}} \times 100 \; \leq \; 90\%